FMP
NASDAQ
0.696 USD
0.0013 (0.187%)
Dr. Paul A. Wagner Ph.D.
Healthcare
Biotechnology
https://www.fortebiorx.com
NASDAQ
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
0001419041
US34962G1094
34962G109
3060 Pegasus Park Drive
310 618 6994
US
9
Apr 13, 2017
0001419041
NASDAQ
Biotechnology
Healthcare
34962G109
US34962G1094
US
0.7
1.65
35.16k
25.34M
-
0.38-1.29
0.38
-
-
-
-
-0.7
-
https://www.fortebiorx.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.